Siga Technologies (SIGA) Competitors $8.99 -0.01 (-0.11%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$9.00 +0.01 (+0.11%) As of 06:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. IDYA, OCUL, MLYS, IBRX, DNLI, IRON, BEAM, CNTA, BLTE, and AGIOShould you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include IDEAYA Biosciences (IDYA), Ocular Therapeutix (OCUL), Mineralys Therapeutics (MLYS), ImmunityBio (IBRX), Denali Therapeutics (DNLI), Disc Medicine (IRON), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Belite Bio (BLTE), and Agios Pharmaceuticals (AGIO). These companies are all part of the "pharmaceutical products" industry. Siga Technologies vs. Its Competitors IDEAYA Biosciences Ocular Therapeutix Mineralys Therapeutics ImmunityBio Denali Therapeutics Disc Medicine Beam Therapeutics Centessa Pharmaceuticals Belite Bio Agios Pharmaceuticals IDEAYA Biosciences (NASDAQ:IDYA) and Siga Technologies (NASDAQ:SIGA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations. Is IDYA or SIGA more profitable? Siga Technologies has a net margin of 45.73% compared to IDEAYA Biosciences' net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat IDEAYA Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets IDEAYA BiosciencesN/A -31.42% -29.45% Siga Technologies 45.73%40.52%35.62% Which has stronger earnings & valuation, IDYA or SIGA? Siga Technologies has higher revenue and earnings than IDEAYA Biosciences. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEAYA Biosciences$7M309.49-$274.48M-$3.79-6.52Siga Technologies$138.72M4.64$59.21M$1.137.96 Which has more volatility & risk, IDYA or SIGA? IDEAYA Biosciences has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Do analysts prefer IDYA or SIGA? IDEAYA Biosciences presently has a consensus price target of $42.85, suggesting a potential upside of 73.33%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe IDEAYA Biosciences is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEAYA Biosciences 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor IDYA or SIGA? In the previous week, IDEAYA Biosciences had 17 more articles in the media than Siga Technologies. MarketBeat recorded 19 mentions for IDEAYA Biosciences and 2 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.95 beat IDEAYA Biosciences' score of 0.46 indicating that Siga Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEAYA Biosciences 2 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Siga Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in IDYA or SIGA? 98.3% of IDEAYA Biosciences shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 2.5% of IDEAYA Biosciences shares are held by insiders. Comparatively, 2.0% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummarySiga Technologies beats IDEAYA Biosciences on 9 of the 16 factors compared between the two stocks. Get Siga Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSiga TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$644.45M$2.55B$5.73B$10.31BDividend YieldN/A60.31%5.90%4.63%P/E Ratio7.9623.4976.3826.51Price / Sales4.64672.77521.37123.58Price / Cash10.76169.4937.1760.46Price / Book2.985.3313.666.29Net Income$59.21M$32.95M$3.28B$270.51M7 Day Performance3.10%0.10%0.88%1.95%1 Month Performance5.76%3.91%4.67%6.33%1 Year Performance14.09%-3.91%80.92%25.62% Siga Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASiga Technologies1.4304 of 5 stars$8.99-0.1%N/A+12.5%$644.45M$138.72M7.9640IDYAIDEAYA Biosciences3.9625 of 5 stars$23.39-13.9%$45.77+95.7%-32.9%$2.38B$7M-6.1780High Trading VolumeOCULOcular Therapeutix3.9008 of 5 stars$12.71-6.5%$17.20+35.3%+39.3%$2.37B$63.72M-9.93230Positive NewsAnalyst ForecastMLYSMineralys Therapeutics2.9191 of 5 stars$35.93+3.2%$36.60+1.9%+222.6%$2.31BN/A-10.0928Insider TradeIBRXImmunityBio2.5161 of 5 stars$2.41+0.4%$10.75+346.1%-19.5%$2.27B$14.74M-5.02590DNLIDenali Therapeutics4.2948 of 5 stars$15.50+0.5%$33.62+116.9%-56.3%$2.26B$330.53M-5.54430Positive NewsIRONDisc Medicine3.2339 of 5 stars$61.91+1.9%$98.30+58.8%+26.6%$2.11BN/A-13.8530Positive NewsHigh Trading VolumeBEAMBeam Therapeutics3.182 of 5 stars$19.94-4.5%$48.45+143.0%-10.6%$2.11B$63.52M-4.43510Analyst DowngradeCNTACentessa Pharmaceuticals3.1287 of 5 stars$18.03+14.6%$31.45+74.5%+29.6%$2.11B$6.85M-10.07200Insider TradeHigh Trading VolumeBLTEBelite Bio2.5091 of 5 stars$67.51+2.7%$96.67+43.2%+37.3%$2.09BN/A-43.5510News CoverageAnalyst ForecastAGIOAgios Pharmaceuticals4.314 of 5 stars$36.41+1.1%$56.00+53.8%-19.1%$2.09B$40.88M3.31390 Related Companies and Tools Related Companies IDEAYA Biosciences Alternatives Ocular Therapeutix Alternatives Mineralys Therapeutics Alternatives ImmunityBio Alternatives Denali Therapeutics Alternatives Disc Medicine Alternatives Beam Therapeutics Alternatives Centessa Pharmaceuticals Alternatives Belite Bio Alternatives Agios Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siga Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Siga Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIGA Stock Alerts